好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Teriflunomide Significantly Increased Time to First Relapse in TEMSO, TOWER and TOPIC
Multiple Sclerosis
(-)
279
Authors/Disclosures
William D. Honeycutt, MD (Neurology Associates, P.A.)
PRESENTER
Dr. Honeycutt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Honeycutt has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Honeycutt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Viela Bio. Dr. Honeycutt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Honeycutt has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Honeycutt has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. Dr. Honeycutt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Honeycutt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Celegene.
Christine Lebrun Frenay, MD, FAAN (CRCSEP Neurologie) Dr. Lebrun Frenay has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Revue Neurologique. The institution of Dr. Lebrun Frenay has received research support from FRANCE SEP.
John O. King, MD, FRACP, FAAN (Royal Melbourne Hospital) Dr. King has nothing to disclose.
Andrew Chan No disclosure on file
Sandra Vukusic, MD (Hopital Neurologique Pierre Wertheimer) The institution of Dr. Vukusic has received research support from Biogen. The institution of Dr. Vukusic has received research support from Janssen. The institution of Dr. Vukusic has received research support from Merck. The institution of Dr. Vukusic has received research support from Novartis. The institution of Dr. Vukusic has received research support from Roche.
Jeffrey L. Gross, MD (Yale School of Medicine) No disclosure on file
Deborah Dukovic No disclosure on file
Philippe Truffinet, MD (Sanofi) Dr. Truffinet has received personal compensation for serving as an employee of Sanofi.
Jean-Pierre Bouchard, MD, FAAN No disclosure on file